Dr. Helft on the CAPTEM Regimen in Patients With Neuroendocrine Tumors
0 Views
administrator
07/09/23
Paul R. Helft, MD, professor of medicine, Indiana University School of Medicine, Indiana University Health Melvin and Bren Simon Cancer Center, discusses the use of capecitabine and temozolomide across gastrointestinal (GI) neuroendocrine tumors.
Show more
Facebook Comments
No comments found